8 hours agoNew test approved for speed diagnosis of COVID-19
Periskopi(6 years ago)
(6 years ago)The US Food and Barna Agency (FDA) has issued authorisation for the emergency use of a third test for COVID-19, at a time of increasing demand worldwide for faster diagnosis. The word is for the “test The riverDx” with antigen and for it, despite authorisation, has warned it is for a percentage [...]
The word is for the “test LurataDx” with antigen and for it, despite authorisation, has warned it is for a small percentage less reliable than it used everywhere, PCR, broadcast time.net writing AP.
Entering the market along with other antigent tests, “Quidel” and “BD”, which has been authorized in May and July respectively, is combining the use of a flurecent device equipped with the instrument that generates the result in just 12 minutes.
This length is approximately the same as that to the similar tests of “Quidel” and “BD”. The agency has announced that the scale and low cost of this test will help increase testing capacities.
software company “LudraDx” has collaborated with “Chembio Diaagnostics” to develop this type of test for diagnosing the presence of the new choreography, which causes COVID-19.
The London-based company's test has been developed to detect the antigen of nucleocapsida protein through noses and can generate results 12 minutes after performing the test on symptoms.
